Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print

Industry News

Related Searches:

Filter by:

AMRI Acquires Hyaluron
June 15, 2010
$27 million buy adds prefilled syringe capacity to AMRI offerings   Read More »
Xcellerex To Build New Bio-Facility
June 10, 2010
Xcellerex, Inc. began construction of a cGMP FlexFactory biomanufacturing facility at its headquarters in Marlborough, MA, with completion scheduled for September 2010.   Read More »
Nextrials, Formedix Integrate Trial Design Tools
June 10, 2010
Nextrials, Inc. has integrated its EDC and clinical trial data management platform Prism with the study design tools offered by Formedix, which includes database design tools based on CDISC data standards.   Read More »
DSM To Manufacture Novacta Compound For Trials
June 9, 2010
DSM BioSolutions has entered into an agreement with Novacta Biosystems Ltd. for the process development and cGMP production of its C. difficile molecule, a new class of lantibiotic compounds.   Read More »
Enavail To Build New CGMP Facility
June 9, 2010
Enavail, LLC, a particle engineering company has plans to build a new cGMP facility in the Abilene Life Sciences Accelerator (ALSA).   Read More »
Covance Adds New Biorepository Facility
June 9, 2010
Covance, Inc. has opened a new 20,000-sq.-ft. biorepository facility at its Greenfield, IN location, dedicated to long-term storage of clinical trial specimens.   Read More »
QPharma Launches Engineering Services
June 8, 2010
QPharma, Inc. has launched its Engineering Services group, which will provide the resources necessary to manage, design, construct, commission, and validate the execution of projects for the life sciences and related industries.   Read More »
Grifols To Acquire Talecris
June 7, 2010
Barcelona-based Grifols SA will acquire Talecris Biotherapeutics Holdings Corp. for $3.4 billion in cash and stock, expanding its U.S. market share for blood-plasma products.   Read More »
Quintiles Adds Suite Of PI3K Biomarker Assays
June 7, 2010
Quintiles has added a comprehensive suite of biomarker assays to investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development.   Read More »
Pfizer Recalls IV Drugs Due To Non-Sterility
June 4, 2010
Pfizer is voluntarily recalling all lots of Metronidazole, Ciprofloxacin and Ondansetron intravenous products due to the presence of floating matter and non-sterility discovered by the manufacturer Claris Laboratories.   Read More »
Biovail Acquires Parkinson’s Drug Target
June 3, 2010
Biovail Laboratories International has entered into a license agreement with Kyowa Hakko Kirin Co. under which Biovail has acquired the U.S. and Canadian rights to commercialize products containing istradefylline, a new chemical entity targeted for the tr   Read More »
BioScreen Successfully Completes Inspection At Torrance Lab
June 2, 2010
BioScreen Testing Services has successfully completed an FDA cGMP inspection of its Torrance lab operations.   Read More »
Centocor Buys RespiVert
June 1, 2010
UK firm was advancing respiratory compounds in COPD, CF   Read More »
AAIPhrma Services Expands Lab In Durham
June 1, 2010
AAIPharma Services will open new laboratory facilities in Durham, NC, consolidating its Chapel Hill, NC labs into one site. "This is the first of many anticipated initiatives we are making to improve our laboratory footprint and offer our custom…   Read More »
Teva To Stop Manufacturing Propofol
May 28, 2010
Teva Pharmaceutical Industries will discontinue manufacturing the sedation drug propofol.   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: